SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: vestor who wrote (1596)1/12/2000 6:35:00 PM
From: harkenman  Respond to of 1837
 
What is surprising the number of shorts that this stock has. This is whats keeping the price low. Once positive earnings are announced price will be driven by
a. shorts covering
b. fundamentals
c. speculators driving up the cost

In the good old days (during ANDA review and before the FDA made DRMD file an NDA) stock was hovering in the 20's. With APRI and other approvals I dare say stock will easily hit $25-30 by 2nd Q